A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens
Public ClinicalTrials.gov record NCT04158466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Safety and Efficacy of a Kalifilcon A Contact Lens for Daily Disposable Use
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
Study identification
- NCT ID
- NCT04158466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Interventions
- Kalifilcon A Daily Disposable Contact Lenses Device
- Biotrue ONEday Daily Disposable Contact Lenses Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2019 (Actual)
- Primary completion
- Nov 12, 2019 (Actual)
- Completion
- Nov 12, 2019 (Actual)
- Last update posted
- Nov 19, 2020
2019
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 8 | Los Angeles | California | 90012 | — |
| Bausch Site 9 | San Francisco | California | 94112 | — |
| Bausch Site 10 | Torrance | California | 90503 | — |
| Bausch Site 12 | Torrance | California | 90505 | — |
| Bausch Site 6 | Sarasota | Florida | 34237 | — |
| Bausch Site 16 | Honolulu | Hawaii | 96814 | — |
| Bausch Site 4 | ‘Aiea | Hawaii | 96701 | — |
| Bausch Site 7 | Pittsburg | Kansas | 66762 | — |
| Bausch Site 11 | Bloomington | Minnesota | 61701 | — |
| Bausch Site 1 | St Louis | Missouri | 63144 | — |
| Bausch Site 13 | Vestal | New York | 13850 | — |
| Bausch Site 2 | State College | Pennsylvania | 16801 | — |
| Bausch Site 14 | Brentwood | Tennessee | 37027 | — |
| Bausch Site 5 | Memphis | Tennessee | 38119 | — |
| Bausch Site 3 | Nashville | Tennessee | 37205 | — |
| Bausch Site 15 | New Berlin | Wisconsin | 53151 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04158466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04158466 live on ClinicalTrials.gov.